Lovastatin, not Simvastatin, Corrects Core Phenotypes in the Fragile X Mouse Model. (2019)

First Author: Muscas M
Attributed to:  Targeting ERK and mTOR for the treatment of fragile X syndrome funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1523/eneuro.0097-19.2019

PubMed Identifier: 31147392

Publication URI: http://europepmc.org/abstract/MED/31147392

Type: Journal Article/Review

Volume: 6

Parent Publication: eNeuro

Issue: 3

ISSN: 2373-2822